0001213900-22-042957.txt : 20220729
0001213900-22-042957.hdr.sgml : 20220729
20220729161653
ACCESSION NUMBER: 0001213900-22-042957
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220729
DATE AS OF CHANGE: 20220729
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAY RUSSELL T
CENTRAL INDEX KEY: 0001225960
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 221121033
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4/A
1
ownership.xml
X0306
4/A
2022-05-19
2022-05-23
0
0001690080
180 Life Sciences Corp.
ATNF
0001225960
RAY RUSSELL T
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
1
0
0
0
Common Stock
2022-05-19
4
A
0
10570
1.36
A
15298
D
Non-Qualified Stock Option (right to buy)
1.36
2022-05-19
4
A
0
21000
0.0
A
2032-05-19
Common Stock
21000
21000
D
Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
This Form 4/A is being filed to correct the number of shares held by the Reporting Person after the transaction reported above which was incorrect in the original filing.
/s/ Russell T. Ray
2022-07-29